A study to assess the safety, tolerability, and efficacy of switching patients currently on oral bisphosphonate to zoledronic acid.
Phase of Trial: Phase III
Latest Information Update: 26 Apr 2012
At a glance
- Drugs Bisphosphonates; Zoledronic acid
- Indications Postmenopausal osteoporosis
- Focus Registrational; Therapeutic Use
- 26 Apr 2012 Investigational drug identified as (Bisphosphonates) as reported by ClinicalTrials.gov.
- 26 Apr 2012 Actual end date (Dec 2005) added as reported by ClinicalTrials.gov.
- 26 Apr 2012 Company (Novartis Pharmaceuticals Corporatio) added to the associations field as reported by ClinicalTrials.gov.